Patents by Inventor Richard Vega

Richard Vega has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240144929
    Abstract: Systems and methods for managing multiple voice assistants are disclosed. Audio input is received via one or more microphones of a playback device. A first activation word is detected in the audio input via the playback device. After detecting the first activation word, the playback device transmits a voice utterance of the audio input to a first voice assistant service (VAS). The playback device receives, from the first VAS, first content to be played back via the playback device. The playback device also receives, from a second VAS, second content to be played back via the playback device. The playback device plays back the first content while suppressing the second content. Such suppression can include delaying or canceling playback of the second content.
    Type: Application
    Filed: January 11, 2024
    Publication date: May 2, 2024
    Inventors: Ryan Richard Myers, Luis R. Vega Zayas, Sangah Park
  • Publication number: 20210300882
    Abstract: Formulations and methods for reducing blood glucose and/or increasing insulin signaling in a subject have been developed. The formulations include SBI-477 and compounds based on SBI-477 i.e., SBI-477 analogs (collectively, SBI-477 compounds) and/or Mondo family inhibitors, in an effective amount to inhibit intracellular lipid accumulation and/or increase cellular glucose uptake when compared to levels in a control subject not administered the composition. Also disclosed are methods of reducing intracellular lipid accumulation and/or increase glucose uptake in a subject in need thereof. The method includes administering to the subject an effective amount of SBI-477 compounds and/or Mondo family inhibitor to reducing intracellular lipid accumulation and/or increase glucose uptake in the subject.
    Type: Application
    Filed: June 8, 2021
    Publication date: September 30, 2021
    Applicant: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
    Inventors: Daniel Kelly, Richard Vega, Hampton Sessions, Teresa Leone, Byungyong Ahn, Satyamaheshwar Peddibhotla
  • Patent number: 11028061
    Abstract: Formulations and methods for reducing blood glucose and/or increasing insulin signaling in a subject have been developed. The formulations include SBI-477 and compounds based on SBI-477 i.e., SBI-477 analogs (collectively, SBI-477 compounds) and/or Mondo family inhibitors, in an effective amount to inhibit intracellular lipid accumulation and/or increase cellular glucose uptake when compared to levels in a control subject not administered the composition. Also disclosed are methods of reducing intracellular lipid accumulation and/or increase glucose uptake in a subject in need thereof. The method includes administering to the subject an effective amount of SBI-477 compounds and/or Mondo family inhibitor to reducing intracellular lipid accumulation and/or increase glucose uptake in the subject.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: June 8, 2021
    Assignee: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
    Inventors: Daniel Kelly, Richard Vega, Hampton Sessions, Teresa Leone, Byungyong Ahn, Satyamaheshwar Peddibhotla
  • Publication number: 20180222874
    Abstract: Formulations and methods for reducing blood glucose and/or increasing insulin signaling in a subject have been developed. The formulations include SBI-477 and compounds based on SBI-477 i.e., SBI-477 analogs (collectively, SBI-477 compounds) and/or Mondo family inhibitors, in an effective amount to inhibit intracellular lipid accumulation and/or increase cellular glucose uptake when compared to levels in a control subject not administered the composition. Also disclosed are methods of reducing intracellular lipid accumulation and/or increase glucose uptake in a subject in need thereof. The method includes administering to the subject an effective amount of SBI-477 compounds and/or Mondo family inhibitor to reducing intracellular lipid accumulation and/or increase glucose uptake in the subject.
    Type: Application
    Filed: July 27, 2016
    Publication date: August 9, 2018
    Applicant: Sanford Bumham Prebys Medical Discovery Imstitute
    Inventors: Daniel Kelly, Richard Vega, Hampton Sessions, Teresa Leone, Byungyong Ahn, Satyamaheshwar Peddibhotla
  • Patent number: 6030026
    Abstract: A tent enclosure for use with a pickup truck having an open cargo bed, upstanding side walls, and a rigid, flat tonneau cover pivotally connected near a front end of the upstanding side walls, comprising a one-piece flexible covering having a main sleeve section, two side sections, and a rear section extending from the sleeve section along the side and rear edges thereof, respectively. The sleeve section comprises a pair of opposed fabric panels affixed together along the side and rear edges thereof to form an interior compartment for receiving the tonneau cover. The tent enclosure is supported in its raised condition by inserting the tonneau cover into the interior compartment of the sleeve section, and supporting the tonneau cover in an inclined position with two support poles placed between the tonneau cover and the cargo bed of the truck. The side sections are lowered and secured to the truck by means of a plurality of elastic cords with hooks extending downward from the side sections.
    Type: Grant
    Filed: September 28, 1998
    Date of Patent: February 29, 2000
    Inventors: Pete B Vega, Richard Vega, George Vega
  • Patent number: D267809
    Type: Grant
    Filed: February 12, 1981
    Date of Patent: February 1, 1983
    Assignee: Pfeiler & Associates, Engineers, Inc.
    Inventors: Vernon L. Lowery, Richard Vega